D Umesh, A Sivaramakrishnan, V Naveen Kumar, Arumugam Pothipillai
{"title":"Type and Screen Method versus Antihuman Globulin Crossmatch in Pretransfusion Testing: A Cross-sectional Study","authors":"D Umesh, A Sivaramakrishnan, V Naveen Kumar, Arumugam Pothipillai","doi":"10.7860/jcdr/2023/65847.18364","DOIUrl":null,"url":null,"abstract":"Introduction: Blood transfusion remains the primary modality of treatment for many serious and common diseases. According to the International Society of Blood Transfusion (ISBT), there are about 349 blood group antigens, out of which only about 25-28 antigens are known to cause acute or delayed type of haemolytic transfusion reactions which could be prevented by Pretransfusion Testing (PTT). Regulated pretransfusion tests include ABO blood grouping, Rh typing, antibody detection, antibody identification and compatibility testing. The purpose of compatibility tests is to demonstrate invitro red cell antigen-antibody reaction. The Antihuman Globulin (AHG) crossmatch testing can assure ABO compatibility between donor and patient blood as well as detect most clinically significant antibodies. Type and Screen (T&S) is a procedure carried out as part of PTT in which the recipient’s blood sample is tested for ABO group, RhD T&S for unexpected antibodies. Aim: To compare T&S method of PTT with AHG crossmatch. Materials and Methods: This cross-sectional study was conducted in the department of Transfusion medicine at Government Royapettah Hospital, Chennai and The Tamil Nadu Dr. MGR Medical University, Chennai, Tamil Nadu, India from June 2012 to December 2013. T&S was performed on 1,040 recipients’ (510 males and 530 females) samples. All these samples were subjected to AHG crossmatch with ABO group and RhD type matched donor samples to assess the compatibility between donor and recipient by using column agglutination technology. Statistical analysis was carried out using Statistical Package for the Social Sciences (SPSS) version 11.0. Results: The prevalence of unexpected antibodies in the recipient population was 1.06%. Among the 1,040 recipients’ blood samples, 11 samples were found to have unexpected antibodies. Out of these 11 samples, 10 showed exact antibodies and the remaining one sample with negative antibody screening was found to be incompatible with AHG crossmatch. The sensitivity and specificity of T&S method in comparison to AHG crossmatch was 87.50% and 99.71%, respectively. Conclusion: The sensitivity and specificity of T&S is as acceptable as AHG crossmatch. However, in view of one sample with false negative antibody screening in the study population, it is imperative to know the phenotyping of Red Blood Cells (RBC) antigens of the native population before getting away with AHG crossmatch.","PeriodicalId":15483,"journal":{"name":"JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH","volume":"18 1","pages":"0"},"PeriodicalIF":0.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7860/jcdr/2023/65847.18364","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Blood transfusion remains the primary modality of treatment for many serious and common diseases. According to the International Society of Blood Transfusion (ISBT), there are about 349 blood group antigens, out of which only about 25-28 antigens are known to cause acute or delayed type of haemolytic transfusion reactions which could be prevented by Pretransfusion Testing (PTT). Regulated pretransfusion tests include ABO blood grouping, Rh typing, antibody detection, antibody identification and compatibility testing. The purpose of compatibility tests is to demonstrate invitro red cell antigen-antibody reaction. The Antihuman Globulin (AHG) crossmatch testing can assure ABO compatibility between donor and patient blood as well as detect most clinically significant antibodies. Type and Screen (T&S) is a procedure carried out as part of PTT in which the recipient’s blood sample is tested for ABO group, RhD T&S for unexpected antibodies. Aim: To compare T&S method of PTT with AHG crossmatch. Materials and Methods: This cross-sectional study was conducted in the department of Transfusion medicine at Government Royapettah Hospital, Chennai and The Tamil Nadu Dr. MGR Medical University, Chennai, Tamil Nadu, India from June 2012 to December 2013. T&S was performed on 1,040 recipients’ (510 males and 530 females) samples. All these samples were subjected to AHG crossmatch with ABO group and RhD type matched donor samples to assess the compatibility between donor and recipient by using column agglutination technology. Statistical analysis was carried out using Statistical Package for the Social Sciences (SPSS) version 11.0. Results: The prevalence of unexpected antibodies in the recipient population was 1.06%. Among the 1,040 recipients’ blood samples, 11 samples were found to have unexpected antibodies. Out of these 11 samples, 10 showed exact antibodies and the remaining one sample with negative antibody screening was found to be incompatible with AHG crossmatch. The sensitivity and specificity of T&S method in comparison to AHG crossmatch was 87.50% and 99.71%, respectively. Conclusion: The sensitivity and specificity of T&S is as acceptable as AHG crossmatch. However, in view of one sample with false negative antibody screening in the study population, it is imperative to know the phenotyping of Red Blood Cells (RBC) antigens of the native population before getting away with AHG crossmatch.
输血仍然是许多严重和常见疾病的主要治疗方式。根据国际输血学会(ISBT)的资料,大约有349种血型抗原,其中只有大约25-28种抗原已知会引起急性或延迟型溶血输血反应,这些反应可以通过输血前检测(PTT)来预防。输血前检测包括ABO血型、Rh血型、抗体检测、抗体鉴定和相容性检测。相容性试验的目的是证明体外红细胞抗原-抗体反应。抗人球蛋白(anti - human Globulin, AHG)交叉配型检测可以保证供者和患者血液ABO的相容性,并检测出大多数临床重要的抗体。类型和筛选(T&S)是作为PTT的一部分进行的一项程序,其中对受体的血液样本进行ABO组检测,RhD T&S检测意外抗体。目的:比较T&S法PTT与AHG交叉配准。材料和方法:本横断面研究于2012年6月至2013年12月在印度钦奈的Government Royapettah医院和泰米尔纳德邦的the Tamil Nadu Medical University的输血医学系进行。对1040名接受者(510名男性和530名女性)的样本进行了T&S。采用柱凝集技术将所有供体样本与ABO组和RhD型匹配供体样本进行AHG交叉配型,评估供体与受体的相容性。统计分析使用社会科学统计软件包(SPSS) 11.0版本进行。结果:受体人群意外抗体检出率为1.06%。在1040名接受者的血液样本中,有11份样本被发现有意想不到的抗体。在这11份样本中,有10份显示出准确的抗体,其余1份抗体筛选阴性的样本发现与AHG交叉配型不相容。T&S法与AHG交叉比对的敏感性和特异性分别为87.50%和99.71%。结论:T&S的敏感性和特异性与AHG交叉配准相同。然而,鉴于研究人群中有一份抗体筛查假阴性的样本,在进行AHG交叉配型之前,有必要了解当地人群的红细胞(Red Blood Cells, RBC)抗原表型。